Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Morris

Showing results (751-760 of 767) with videos related to

Pageof 77
Sort By:
Scientific Reports|October 10, 2018
Author Correction: Accuracy and Precision of Tidal Wetland Soil Carbon Mapping in the Conterminous United StatesJames R Holmquist, Lisamarie Windham-Myers, Norman Bliss, et al.
Nature Biotechnology|November 2, 2021
Improved prediction of immune checkpoint blockade efficacy across multiple cancer typesDiego Chowell, Seong-Keun Yoo, Cristina Valero, et al.
Journal of the National Cancer Institute|July 30, 2020
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic EfficacyKenneth L Pitter, Dana L Casey, Yue C Lu, et al.
Cell|July 28, 2018
The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric DisordersA Jeremy Willsey, Montana T Morris, Sheng Wang, et al.
Nature Genetics|May 21, 2013
The mutational landscape of adenoid cystic carcinomaAllen S Ho, Kasthuri Kannan, David M Roy, et al.
Nature Medicine|January 6, 2025
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical dataSeong-Keun Yoo, Conall W Fitzgerald, Byuri Angela Cho, et al.
Science Immunology|September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancerGiacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Science Advances|November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanomaGiuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Nature Communications|February 25, 2016
FAT1 mutations cause a glomerulotubular nephropathyHeon Yung Gee, Carolin E Sadowski, Pardeep K Aggarwal, et al.
Journal of the National Cancer Institute|January 11, 2021
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC TrialNadeem Riaz, Eric Sherman, Xin Pei, et al.
Pageof 77

Showing results (751-760 of 767) with videos related to

Sort By:
Pageof 77
Scientific Reports|October 10, 2018
Author Correction: Accuracy and Precision of Tidal Wetland Soil Carbon Mapping in the Conterminous United StatesJames R Holmquist, Lisamarie Windham-Myers, Norman Bliss, et al.
Nature Biotechnology|November 2, 2021
Improved prediction of immune checkpoint blockade efficacy across multiple cancer typesDiego Chowell, Seong-Keun Yoo, Cristina Valero, et al.
Journal of the National Cancer Institute|July 30, 2020
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic EfficacyKenneth L Pitter, Dana L Casey, Yue C Lu, et al.
Cell|July 28, 2018
The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric DisordersA Jeremy Willsey, Montana T Morris, Sheng Wang, et al.
Nature Genetics|May 21, 2013
The mutational landscape of adenoid cystic carcinomaAllen S Ho, Kasthuri Kannan, David M Roy, et al.
Nature Medicine|January 6, 2025
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical dataSeong-Keun Yoo, Conall W Fitzgerald, Byuri Angela Cho, et al.
Science Immunology|September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancerGiacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Science Advances|November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanomaGiuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Nature Communications|February 25, 2016
FAT1 mutations cause a glomerulotubular nephropathyHeon Yung Gee, Carolin E Sadowski, Pardeep K Aggarwal, et al.
Journal of the National Cancer Institute|January 11, 2021
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC TrialNadeem Riaz, Eric Sherman, Xin Pei, et al.
Pageof 77